GT Biopharma, Inc. (GTBP)
0.7055
+0.08
(+12.50%)
USD |
NASDAQ |
Dec 16, 15:02
GT Biopharma Research and Development Expense (Annual): 5.798M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Geron Corp. | 103.74M |
| Regeneron Pharmaceuticals, Inc. | 4.624B |
| SELLAS Life Sciences Group, Inc. | 19.10M |
| Xencor, Inc. | 227.69M |
| Zymeworks, Inc. | 134.62M |